Oral Sulopenem Versus Amoxicillin/Clavulanate for Uncomplicated Urinary Tract Infection in Adult Women

NCT ID: NCT05584657

Last Updated: 2024-11-20

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

2229 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-10-18

Study Completion Date

2023-11-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Study 310 is a clinical study which compares the effectiveness of oral sulopenem versus oral amoxicillin/clavulanate for the treatment of adult women with uncomplicated urinary tract infection.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

IT001-310 is a Phase 3, randomized, multicenter, double-blind, double dummy, controlled study to compare oral sulopenem etzadroxil/probenecid (oral sulopenem) to oral amoxicillin/clavulanate for the treatment of adult female patients with uncomplicated urinary tract infection. Approximately 1966 adult women with uncomplicated urinary tract infection will be randomized in a 1:1 fashion to receive either oral sulopenem etzadroxil/probenecid or oral amoxicillin/clavulanate twice daily for 5 days. The primary outcome measure for efficacy evaluation will be the overall success (combined clinical and microbiologic success) on Day 12 (± 1 day)/Test of Cure (TOC).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Urinary Tract Infections Cystitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Sulopenem etzadroxil/probenecid

Sulopenem etzadroxil/probenecid 500 mg/500 mg PO twice daily for 5 days

Group Type EXPERIMENTAL

Sulopenem etzadroxil/probenecid

Intervention Type DRUG

Oral sulopenem twice daily for 5 days

Amoxicillin/clavulanate

Amoxicillin/clavulanate PO twice daily for 5 days

Group Type ACTIVE_COMPARATOR

Amoxicillin/clavulanate

Intervention Type DRUG

Oral Augmentin twice daily for 5 days

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Sulopenem etzadroxil/probenecid

Oral sulopenem twice daily for 5 days

Intervention Type DRUG

Amoxicillin/clavulanate

Oral Augmentin twice daily for 5 days

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Oral sulopenem Augmentin

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female patients ≥18 years of age with ≥24 hours and ≤96 hours of urinary symptoms attributable to a UTI
* Two of the following signs and symptoms of uUTI: urinary frequency, urinary urgency, pain or burning on micturition, suprapubic pain.
* A mid-stream urine specimen with evidence of pyuria as defined by either a machine-read dipstick positive for leukocyte esterase OR at least 10 white blood cells per cubic millimeter on microscopic analysis of unspun urine OR white blood cell count ≥10 cells/high-powered field (HPF) in the sediment of a spun urine

Exclusion Criteria

* Presence of signs and symptoms suggestive of acute pyelonephritis defined as: fever (temperature \> 38° Celsius), chills, costovertebral angle tenderness, flank pain, nausea, and/or vomiting
* Receipt of antibacterial drug therapy potentially effective as treatment of uUTI within the prior 7 days
* Concurrent use of non-study treatments that would have a potential effect on outcome evaluations in patients with uUTI, including analgesics (e.g., non-steroidal anti-inflammatory drugs, aspirin, paracetamol etc.), phenazopyridine, and cranberry products.
* Any anatomical abnormality of the urinary tract, including surgically modified urinary tract anatomy, and obstructive uropathy due to nephrolithiasis, stricture, tumor, or fibrosis
* Ongoing urinary retention
* Neurogenic bladder
* Current resident of a long-term care facility
* Instrumentation of urinary tract in the previous 30 days
* An indwelling urinary catheter, ureteral stent or other foreign material in the urinary tract
* Any history of trauma to the pelvis or urinary tract
* Receiving hemodialysis, hemofiltration, peritoneal dialysis, or had a renal transplant
* History of allergy or hypersensitivity to carbapenems, β-lactams or probenecid, as formulated with their excipients
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Iterum Therapeutics, International Limited

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sailaja Puttagunta, MD

Role: STUDY_DIRECTOR

Iterum Therapeutics

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Medical Facility

Cullman, Alabama, United States

Site Status

Medical Facility

Saraland, Alabama, United States

Site Status

Medical Facility

Sheffield, Alabama, United States

Site Status

Medical Facility

Peoria, Arizona, United States

Site Status

Medical Facility3

Phoenix, Arizona, United States

Site Status

Medical Facility

Phoenix, Arizona, United States

Site Status

Medical Facility2

Phoenix, Arizona, United States

Site Status

Medical Facility

Tucson, Arizona, United States

Site Status

Medical Facility2

Hot Springs, Arkansas, United States

Site Status

Medical Facility

Hot Springs, Arkansas, United States

Site Status

Medical Facility

Bakersfield, California, United States

Site Status

Medical Facility

Chula Vista, California, United States

Site Status

Medical Facility

Fullerton, California, United States

Site Status

Medical Facility

Garden Grove, California, United States

Site Status

Medical Facility

Huntington Beach, California, United States

Site Status

Medical Facility 2

Huntington Park, California, United States

Site Status

Medical Facility

Huntington Park, California, United States

Site Status

Medical Facility

Irvine, California, United States

Site Status

Medical Facility

La Mesa, California, United States

Site Status

Medical Facility

Lancaster, California, United States

Site Status

Medical Facility

Lomita, California, United States

Site Status

Medical Facility2

Los Angeles, California, United States

Site Status

Medical Facility

Los Angeles, California, United States

Site Status

Medical Facility

Pomona, California, United States

Site Status

Medical Facility

Sacramento, California, United States

Site Status

Medical Facility

San Diego, California, United States

Site Status

Medical Facility

Upland, California, United States

Site Status

Medical Facility

Victorville, California, United States

Site Status

Medical Facility

Grand Junction, Colorado, United States

Site Status

Medical Facility

Lakewood, Colorado, United States

Site Status

Medical Facility

Aventura, Florida, United States

Site Status

Medical Facility

Boynton Beach, Florida, United States

Site Status

Medical Facility

Cape Coral, Florida, United States

Site Status

Medical Facility

Doral, Florida, United States

Site Status

Medical Facility

Edgewater, Florida, United States

Site Status

Medical Facility

Hialeah, Florida, United States

Site Status

Medical Facility

Hollywood, Florida, United States

Site Status

Medical Facility

Homestead, Florida, United States

Site Status

Medical Facility

Lake Worth, Florida, United States

Site Status

Medical Facility2

Lake Worth, Florida, United States

Site Status

Medical Facility

Leesburg, Florida, United States

Site Status

Medical Facility3

Miami, Florida, United States

Site Status

Medical Facility2

Miami, Florida, United States

Site Status

Medical Facility

Miami, Florida, United States

Site Status

Medical Facility9

Miami, Florida, United States

Site Status

Medical Facility5

Miami, Florida, United States

Site Status

Medical Facility8

Miami, Florida, United States

Site Status

Medical Facility6

Miami, Florida, United States

Site Status

Medical Facility7

Miami, Florida, United States

Site Status

Medical Facility4

Miami, Florida, United States

Site Status

Medical Facility

Miami Beach, Florida, United States

Site Status

Medical Facility

Miami Gardens, Florida, United States

Site Status

Medical Facility2

Miami Lakes, Florida, United States

Site Status

Medical Facility

Miami Lakes, Florida, United States

Site Status

Medical Facility

Orlando, Florida, United States

Site Status

Medical Facility2

Orlando, Florida, United States

Site Status

Medical Facility

Ormond Beach, Florida, United States

Site Status

Medical Facility

Pompano Beach, Florida, United States

Site Status

Medical Facility

Sweetwater, Florida, United States

Site Status

Medical Facility

Tamarac, Florida, United States

Site Status

Medical Facility

Tampa, Florida, United States

Site Status

Medical Facility3

Tampa, Florida, United States

Site Status

Medical Facility4

Tampa, Florida, United States

Site Status

Medical Facility2

Tampa, Florida, United States

Site Status

Medical Facility5

Tampa, Florida, United States

Site Status

Medical Facility

Winter Haven, Florida, United States

Site Status

Medical Facility3

Atlanta, Georgia, United States

Site Status

Medical Facility2

Atlanta, Georgia, United States

Site Status

Medical Facility

Atlanta, Georgia, United States

Site Status

Medical Facility

Decatur, Georgia, United States

Site Status

Medical Facility

Lawrenceville, Georgia, United States

Site Status

Medical Facility

Union City, Georgia, United States

Site Status

Medical Facility

Woodstock, Georgia, United States

Site Status

Medical Facility

Blackfoot, Idaho, United States

Site Status

Medical Facility2

Idaho Falls, Idaho, United States

Site Status

Medical Facility

Idaho Falls, Idaho, United States

Site Status

Medical Facility

Chicago, Illinois, United States

Site Status

Medical Facility

Eunice, Louisiana, United States

Site Status

Medical Facility

Mandeville, Louisiana, United States

Site Status

Medical Facility

Marrero, Louisiana, United States

Site Status

Medical Facility

Metairie, Louisiana, United States

Site Status

Medical Facility

New Orleans, Louisiana, United States

Site Status

Medical Facility2

New Orleans, Louisiana, United States

Site Status

Medical Facility

Prairieville, Louisiana, United States

Site Status

Medical Facility

Shreveport, Louisiana, United States

Site Status

Medical Facility

Columbia, Maryland, United States

Site Status

Medical Facility

Oxon Hill, Maryland, United States

Site Status

Medical Facility

Towson, Maryland, United States

Site Status

Medical Facility

Fayette, Mississippi, United States

Site Status

Medical Facility

Gulfport, Mississippi, United States

Site Status

Medical Facility

Jackson, Mississippi, United States

Site Status

Medical Facility

Ridgeland, Mississippi, United States

Site Status

Medical Facility

Great Falls, Montana, United States

Site Status

Medical Facility

Kalispell, Montana, United States

Site Status

Medical Facility

Missoula, Montana, United States

Site Status

Medical Facility2

Las Vegas, Nevada, United States

Site Status

Medical Facility

Las Vegas, Nevada, United States

Site Status

Medical Facility2

Albuquerque, New Mexico, United States

Site Status

Medical Facility

Albuquerque, New Mexico, United States

Site Status

Medical Facility

Brooklyn, New York, United States

Site Status

Medical Facility2

Brooklyn, New York, United States

Site Status

Medical Facility

Garden City, New York, United States

Site Status

Medical Facility

Schenectady, New York, United States

Site Status

Medical Facility

The Bronx, New York, United States

Site Status

Medical Facility

Charlotte, North Carolina, United States

Site Status

Medical Facility

Greensboro, North Carolina, United States

Site Status

Medical Facility

New Bern, North Carolina, United States

Site Status

Medical Facility

Winston-Salem, North Carolina, United States

Site Status

Medical Facility

Cincinnati, Ohio, United States

Site Status

Medical Facility2

Columbus, Ohio, United States

Site Status

Medical Facility

Columbus, Ohio, United States

Site Status

Medical Facility

Dayton, Ohio, United States

Site Status

Medical Facility2

Dayton, Ohio, United States

Site Status

Medical Facility

Lima, Ohio, United States

Site Status

Medical Facility

Middleburg Heights, Ohio, United States

Site Status

Medical Facility

Tulsa, Oklahoma, United States

Site Status

Medical Facility

Eugene, Oregon, United States

Site Status

Medical Facility

Portland, Oregon, United States

Site Status

Medical Facility

Beaver, Pennsylvania, United States

Site Status

Medical Facility

Scottdale, Pennsylvania, United States

Site Status

Medical Facility

Smithfield, Pennsylvania, United States

Site Status

Medical Facility

Upper Saint Clair, Pennsylvania, United States

Site Status

Medical Facility

Charleston, South Carolina, United States

Site Status

Medical Facility

Easley, South Carolina, United States

Site Status

Medical Facility

Greenville, South Carolina, United States

Site Status

Medical Facility

Lancaster, South Carolina, United States

Site Status

Medical Facility

Myrtle Beach, South Carolina, United States

Site Status

Medical Facility

Powdersville, South Carolina, United States

Site Status

Medical Facility

Seneca, South Carolina, United States

Site Status

Medical Facility

Summerville, South Carolina, United States

Site Status

Medical Facility2

Chattanooga, Tennessee, United States

Site Status

Medical Facility

Chattanooga, Tennessee, United States

Site Status

Medical Facility

Hendersonville, Tennessee, United States

Site Status

Medical Facility

Memphis, Tennessee, United States

Site Status

Medical Facility

Nashville, Tennessee, United States

Site Status

Medical Facility

Austin, Texas, United States

Site Status

Medical Facility

Carrollton, Texas, United States

Site Status

Medical Facility2

Carrollton, Texas, United States

Site Status

Medical Facility

Corpus Christi, Texas, United States

Site Status

Medical Facility

Dallas, Texas, United States

Site Status

Medical Facility

Frisco, Texas, United States

Site Status

Medical Facility

Georgetown, Texas, United States

Site Status

Medical Facility2

Houston, Texas, United States

Site Status

Medical Facility

Houston, Texas, United States

Site Status

Medical Facility

Kingwood, Texas, United States

Site Status

Medical Facility

League City, Texas, United States

Site Status

Medical Facility2

McKinney, Texas, United States

Site Status

Medical Facility

McKinney, Texas, United States

Site Status

Medical Facility2

Mesquite, Texas, United States

Site Status

Medical Facility

Mesquite, Texas, United States

Site Status

Medical Facility

Missouri City, Texas, United States

Site Status

Medical Facility

Pearland, Texas, United States

Site Status

Medical Facility2

Plano, Texas, United States

Site Status

Medical Facility

Plano, Texas, United States

Site Status

Medical Facility

San Antonio, Texas, United States

Site Status

Medical Facility 2

Sugar Land, Texas, United States

Site Status

Medical Facility3

Sugar Land, Texas, United States

Site Status

Medical Facility

Sugar Land, Texas, United States

Site Status

Medical Facility 2

Draper, Utah, United States

Site Status

Medical Facility

Draper, Utah, United States

Site Status

Medical Facility

Pleasant Grove, Utah, United States

Site Status

Medical Facility

Salt Lake City, Utah, United States

Site Status

Medical Facility

Falls Church, Virginia, United States

Site Status

Medical Facility

Manassas, Virginia, United States

Site Status

Medical Facility

Norfolk, Virginia, United States

Site Status

Medical Facility

Kingwood, West Virginia, United States

Site Status

Medical Facility

Morgantown, West Virginia, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Puttagunta S, Aronin SI, Gupta J, Das AF, Gupta K, Dunne MW. Sulopenem versus Amoxicillin/Clavulanate for the Treatment of Uncomplicated Urinary Tract Infection. NEJM Evid. 2025 Jul;4(7):EVIDoa2400414. doi: 10.1056/EVIDoa2400414. Epub 2025 Jun 24.

Reference Type DERIVED
PMID: 40552968 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IT001-310

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.